| A | B | C | D | E | F | G | H | I | |
|---|---|---|---|---|---|---|---|---|---|
1 | Company | Ticker | Proprietary Name | Established Name | Indication | PDUFA date | Compound Type | Notes | |
2 | NPS Pharmaceuticals | NPSP | Natpera | synthetic parathyroid hormone | Hypoparathyroidism (rare condition0 | 1/24/2015 | Pushed back 3 months from 10/24/14 | ||
3 | Aeterna Zentaris | AEZS | Solorel | macimorelin | Diagnosis of adult growth hormone deficiency | 11/5/2014 | Rejected 11/6/14 | ||
4 | |||||||||
5 | Source: The Burrill Report | ||||||||
6 | |||||||||
7 | |||||||||
8 | |||||||||
9 | |||||||||
10 | |||||||||
11 |